×
About 3,525 results

ALLMedicine™ Hidradenitis Suppurativa Center

Research & Reviews  1,206 results

Optimizing Intralesional Triamcinolone Dosing for Hidradenitis Suppurativa
https://clinicaltrials.gov/ct2/show/NCT04582669

Jan 21st, 2022 - A double-blinded, randomized, placebo-controlled study examining the relative efficacy of ILTAC-10, ILTAC-20, and ILTAC-40 versus placebo for acute flares of HS in subjects with moderate to severe HS. The duration of the study will be approximatel...

Identification of Biomarkers and Critical Evaluation of Biomarker Validation in Hidrade...
https://doi.org/10.1001/jamadermatol.2021.4926
JAMA Dermatology; Der Sarkissian S, Hessam S et. al.

Jan 20th, 2022 - The identification and validation of biomarkers in hidradenitis suppurativa (HS) has potential to improve the understanding and management of this chronic, burdensome disease. To systematically identify all known HS biomarkers, categorize them by ...

Real-world safety and effectiveness of adalimumab in patients with hidradenitis suppura...
https://doi.org/10.1111/1346-8138.16297
The Journal of Dermatology; Hayashi N, Hayama K et. al.

Jan 19th, 2022 - Hidradenitis suppurativa (HS) is a painful chronic skin disease characterized by abscesses, nodules, and tunnels in the skin. Adalimumab, a monoclonal antibody against tumor necrosis factor-α, is approved for the treatment of HS in Europe, the USA...

Body dysmorphia in common skin diseases: Results of an observational, cross-sectional m...
https://doi.org/10.1111/bjd.21021
The British Journal of Dermatology; Schut C, Dalgard FJ et. al.

Jan 19th, 2022 - Body dysmorphic disorder (BDD) is a common psychiatric disorder associated with high costs for healthcare systems as patients may repeatedly ask for different, often not effective interventions. BDD symptoms are more prevalent in patients with der...

A Study to Test Whether Spesolimab Helps People With a Skin Disease Called Hidradenitis Suppurativa
https://clinicaltrials.gov/ct2/show/NCT04762277

Jan 19th, 2022 - This study is open to adults with a chronic inflammatory skin disease called hidradenitis suppurativa. The purpose of this study is to find out whether a medicine called spesolimab helps people with moderate to severe hidradenitis suppurativa. Par...

see more →

Guidelines  1 results

Updates on treatment guidelines for psoriasis, atopic dermatitis (eczema), hidradenitis...
https://www.ncbi.nlm.nih.gov/pubmed/33147660
Dermatology Online Journal; Yim RM, Singh I et. al.

Nov 5th, 2020 - Owing to the evolving COVID-19 pandemic and emerging data regarding immunosuppressant therapies for inflammatory cutaneous diseases, dermatologists are being encouraged to reevaluate their patients' treatment regimens to minimize any potential ris...

see more →

Drugs  1 results see all →

Clinicaltrials.gov  47 results

Optimizing Intralesional Triamcinolone Dosing for Hidradenitis Suppurativa
https://clinicaltrials.gov/ct2/show/NCT04582669

Jan 21st, 2022 - A double-blinded, randomized, placebo-controlled study examining the relative efficacy of ILTAC-10, ILTAC-20, and ILTAC-40 versus placebo for acute flares of HS in subjects with moderate to severe HS. The duration of the study will be approximatel...

A Study to Test Whether Spesolimab Helps People With a Skin Disease Called Hidradenitis Suppurativa
https://clinicaltrials.gov/ct2/show/NCT04762277

Jan 19th, 2022 - This study is open to adults with a chronic inflammatory skin disease called hidradenitis suppurativa. The purpose of this study is to find out whether a medicine called spesolimab helps people with moderate to severe hidradenitis suppurativa. Par...

A Study to Assess Disease Activity and Safety of Subcutaneous Lutikizumab (ABT-981) in Adult Participants With Moderate to Severe Hidradenitis Suppurativa Who Have Failed Anti-Tumor Necrosis Factor...
https://clinicaltrials.gov/ct2/show/NCT05139602

Jan 19th, 2022 - Hidradenitis suppurativa (HS) is a chronic and often painful inflammatory skin disease which includes the forming of lumps, abscesses and scars in areas of the skin such as under the breasts, under armpits, inner thighs, groin and buttocks. Despit...

A Study Investigating Long-term Treatment With Spesolimab in People With a Skin Disease Called Hidradenitis Suppurativa Who Completed a Previous Clinical Trial
https://clinicaltrials.gov/ct2/show/NCT04876391

Jan 18th, 2022 - This study is open to adults with hidradenitis suppurativa who took part in a previous clinical study of a medicine called spesolimab. Participants who completed treatment can join this study. The purpose of this study is to find out how safe spes...

Observational Study Evaluating Long-Term Safety and Effectiveness of Humira in Patients With Hidradenitis Suppurativa
https://clinicaltrials.gov/ct2/show/NCT03894956

Jan 18th, 2022 - The objective of this study is to evaluate the long-term safety and effectiveness of Humira in patients with Hidradenitis Suppurativa (HS) in real-world clinical practice in Japan.

see more →

News  151 results

European Agency Recommends Two New Adalimumab Biosimilars
https://www.medscape.com/viewarticle/959002

Sep 17th, 2021 - The European Medicines Agency's Committee for Medicinal Products for Human Use recommended marketing authorization this week for two new adalimumab biosimilars, Hukyndra and Libmyris. The biosimilars, both developed by STADA Arzneimittel AG, will ...

Adalimumab Adds to Surgery Benefits for Hidradenitis Suppurativa
https://www.medpagetoday.com/dermatology/generaldermatology/94091

Aug 18th, 2021 - Adalimumab (Humira) in addition to surgery for moderate to severe hidradenitis suppurativa (HS) significantly increased the rate of complete response versus surgery alone, a first-ever randomized trial showed. After 12 weeks of preoperative treatm...

Results of Laboratory Monitoring in Patients Taking Isotretinoin for Acne
https://www.mdedge.com/dermatology/article/242754/acne/results-laboratory-monitoring-patients-taking-isotretinoin-acne
Mohammed Al-Haddab, MD, FRCPC, Alanoud Alhuqayl, MD et. al.

Jul 9th, 2021 - Introduced in 1982, isotretinoin is a retinoid derivative that has been widely used to treat various dermatologic conditions such as acne vulgaris, rosacea, hidradenitis suppurativa, and hair folliculitis. 1 It remains one of the most effective dr.

Inpatient care for HS higher for Black and Hispanic patients
https://www.mdedge.com/dermatology/article/241611/medical-dermatology/inpatient-care-hs-higher-black-and-hispanic-patients
Christine Kilgore

Jun 15th, 2021 - Inpatient care utilization for hidradenitis suppurativa (HS) was higher for Black and Hispanic patients, compared with White patients, in an analysis of the 2012-2017 National Inpatient Sample. The differences occurred despite Black and Hispanic p.

Relationship-Centered Care in the Physician-Patient Interaction: Improving Your Understanding of Metacognitive Interventions
https://www.mdedge.com/dermatology/article/241107/practice-management/relationship-centered-care-physician-patient
Christine J. Ko, MD, Rose Kim, MD, MEdHP et. al.

Jun 4th, 2021 - Communication and relationships cannot be taken for granted, particularly in the physician-patient relationship, where life-altering diagnoses may be given. With one diagnosis, someone’s life may be changed, and both physicians and patients need t.

see more →

Patient Education  4 results see all →